STAT+: New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines
The New Mexico attorney general has filed a lawsuit against Gilead Sciences (GILD) and two other major drug makers for allegedly conspiring to block competition to several different HIV medicines, which ultimately caused the state to spend millions of dollars for “excessively overpriced” treatments.
Specifically, the lawsuit details a complicated scheme in which Gilead “deliberately and deceitfully” delayed generic competition for its widely used HIV medicines for several years by, among other things, reaching purportedly anticompetitive settlements to patent litigation with Bristol Myers Squibb (BMY) and Teva Pharmaceuticals (TEVA), which is one of the world’s largest purveyors of generic drugs.
Continue to STAT+ to read the full story…
